Back
Spyre Therapeutics Vs. Nike Industry Stock Comparison
Sell
25
SYRE
Spyre Therapeutics
Last Price:
23.84
Seasonality Move:
8.08%
Sell
17
NKE
Nike
Last Price:
76.06
Seasonality Move:
6.25%
Sell
25
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $23.79. The Score for SYRE is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
17
Nike (NKE)
is a Sell
Is Nike a Buy, Sell or Hold?
- The current Nike [NKE] share price is $76.04. The Score for NKE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- NKE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $23.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing slight selling pressure.
NKE Stock Price Chart
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.08 | Sell |
| Relative Strength Index (14 RSI): | 34.26 | Sell |
| Chaikin Money Flow: | -191676 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.61 - 35.35) | Sell |
| Bollinger Bands (100): | (26.91 - 39.25) | Sell |
NKE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.2 | Sell |
| Relative Strength Index (14 RSI): | 21.68 | Sell |
| Chaikin Money Flow: | -4026097 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.28 - 98.68) | Sell |
| Bollinger Bands (100): | (89.69 - 101.25) | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.65 | Buy |
| 20-day SMA: | 28.94 | Sell |
| 50-day SMA: | 32.57 | Sell |
| 200-day SMA: | 24.7 | Sell |
| 8-day EMA: | 24.52 | Sell |
| 20-day EMA: | 27.6 | Sell |
| 50-day EMA: | 30.92 | Sell |
| 200-day EMA: | 26.88 | Sell |
NKE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 88.2 | Sell |
| 20-day SMA: | 92.27 | Sell |
| 50-day SMA: | 92.61 | Sell |
| 200-day SMA: | 100.01 | Sell |
| 8-day EMA: | 85 | Sell |
| 20-day EMA: | 89.87 | Sell |
| 50-day EMA: | 92.49 | Sell |
| 200-day EMA: | 99.26 | Sell |
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
Nike Earnings Growth & NKE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.48 per share, and a decrease next year of $0.52 per share.
Spyre Therapeutics Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nike Technical Analysis
| Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||